Justices To Clarify What's Fair Game With 'Skinny Labels'
By Ryan Davis · January 20, 2026, 9:13 PM EST
A new U.S. Supreme Court patent case that will require the justices to spell out what generic-drug makers can say when marketing drugs with so-called skinny labels will shape whether and...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login